Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Inference Toolset for Venture Financial Performance Forecasting

USPTO published patent application US20260094176A1 for Juniper Strategies Advising, Inc., covering an inference toolset that gathers venture and market data, generates visual circumplex representations of plan and actual strength scores, calculates indices, identifies disparities, and forecasts financial performance. The application was filed October 2, 2025.

Routine Notice Intellectual Property
Favicon for changeflow.com

Systems and Methods for Demand Planning, Forecasting, and Procurement

The USPTO published patent application US20260094175A1 for a software application that receives construction project item demand data, aggregates it with user inputs, and generates demand forecasts. The application can generate and transmit purchase orders and transfer orders to supply chain systems based on forecasted demand.

Routine Notice Financial Services
Favicon for changeflow.com

Recommendation Evaluation Device for Store Visit Likelihood

USPTO published patent application US20260094174A1 by NTT DOCOMO, INC. The application discloses a recommendation evaluation device that derives visit likelihood evaluations for stores before and after recommendations are made to target users. The system enables comparison of recommendation effectiveness by measuring the difference in visit probability with and without promotional recommendations.

Routine Notice Artificial Intelligence
Favicon for changeflow.com

Visitor Analysis System and Method for Vehicle Tracking via Distributed Cameras

USPTO published patent application US20260094173A1 by NEC Corporation for a visitor analysis system that uses distributed cameras to identify vehicles entering a prescribed region and traces their start point by matching vehicle images with timestamped location data. The system comprises an access unit, vehicle identifying unit, and start point identifying unit. No compliance obligations or deadlines are associated with this publication.

Routine Notice Intellectual Property
Favicon for changeflow.com

Causal validation method for multivariate regression models

USPTO published patent application US20260094172A1 for a causal validation method for multivariate regression models. Inventors Tilman Drerup, Steven Ji, and Toban Wiebe filed the application on September 27, 2024, covering a method to evaluate causal generalizability of models such as marketing mix models. The publication appeared on April 2, 2026.

Routine Notice Technology
Favicon for changeflow.com

Charter flight exchange platform, dynamic asset re-selling system

Charter flight exchange platform, dynamic asset re-selling system

Routine Notice
Favicon for changeflow.com

Small Molecule Degraders and Fluorescent Probes of PXR

USPTO published patent application US20260092058A1 disclosing compounds, compositions, and methods for degrading pregnane X receptor (PXR) protein. The invention relates to decreasing adverse drug reactions associated with administration of anticancer agents, antibacterial agents, non-steroidal anti-inflammatory agents, or anticonvulsant agents. Application No. 18902844 was filed September 30, 2024.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

BCL-XL/BCL-2 Degraders and Uses Thereof

The USPTO published patent application US20260092057A1 for BCL-XL/BCL-2 degrader compounds and methods of using the same for treating conditions such as cancer. The application was filed on May 12, 2023, by inventors including Huijun Dong, Bin Yang, and others, and covers novel chemical compositions under CPC classifications including C07D 417/12, C07D 471/04, and related therapeutic uses.

Routine Notice Intellectual Property
Favicon for changeflow.com

Melanocortin-4 Receptor Agonists for Obesity and Diabetes Treatment

The USPTO published patent application US20260092056A1 for melanocortin-4 receptor agonists developed by eight inventors. The compounds of Formula 1 demonstrate agonist activity against melanocortin-4 receptors and may be useful in preventing or treating obesity, diabetes, inflammation, and erectile dysfunction.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Aromatic Acetylene Derivative, Preparation Method Therefor, And Pharmaceutical Use Thereof

USPTO published patent application US20260092055A1 by Zhejiang Hisun Pharmaceutical Co., Ltd. for aromatic acetylene derivatives useful as LpxC inhibitors for treating bacterial infections. The application covers the chemical compounds, preparation methods, and pharmaceutical compositions. Application No. 19112826 was filed September 28, 2023.

Routine Notice Intellectual Property

Showing 6201–6210 of 42,781 changes

1 619 620 621 622 623 4279

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.